Comprehensive Exploration of Stem Cells in Medicine and Research: An In-Depth Review

Abstract

Stem cells have emerged as a promising avenue in medicine and research, captivating the attention of scientists, healthcare professionals, and the general public. This in-depth review provides a thorough exploration of the various types of stem cells, their potential in treatments, and the ethical considerations surrounding their use. The review highlights the remarkable advancements in understanding stem cells and harnessing their potential to address a wide range of diseases, from Parkinson's and Alzheimer's to heart diseases and cancer. Delving into the legal and ethical discussions surrounding stem cell utilization, the review discusses how scientific progress and ethical frameworks have evolved to address these concerns. Furthermore, the review explores cutting-edge research and groundbreaking trials that have the potential to revolutionize healthcare, including the development of organoids and 3D bioprinting. Acknowledging the complexities and challenges associated with stem cell applications, this review emphasizes the need for a balanced approach that considers both the benefits and implications of stem cell research.

Keywords

Stem cells, Induced pluripotent stem cells, Cell proliferation, Embryonic, Pluripotent, Unipotent

Introduction

Cord blood stem cells have received a lot of attention in the field of medicine because of their qualities and potential, for treating various conditions. These cells, which are collected from the cord after a baby is born offer advantages compared to other sources of stem cells (Bae et al., 2012). For example cord blood stem cells are easily accessible. Can be stored in cord blood banks for use. It's important to note that they are classified as multipotent, which indicates their capability to transform into cell types, [62].

Here are some key points about cord blood stem cells:

1. Collection: After a baby is born cord blood stem cells are usually collected. This procedure is completely painless and does not cause harm to neither the baby nor the mother. The blood is obtained from the cord and placenta once they have been clamped and cut, [63].

2. Stem Cell Banking: Many parents opt to store their babys cord blood in a cord blood bank. This means that the cord blood is processed, frozen, and stored for potential future use. It can be used for the baby or a family member in case they develop certain medical conditions, [64].

3. Medical Uses: Stem cells obtained from cord blood have proven to be effective, in treating a range of diseases and conditions those that affect the blood and system. Illnesses such, as leukemia, lymphoma and specific genetic disorders can be successfully addressed through the transplantation of cord blood stem cells, [65].

4. Compatibility: They are known for their ability to adapt to tissue types making them a potential option, for transplantation when finding an exact tissue match is difficult, [66].

5. Research: Cord blood stem cells are also valuable for scientific research. They can be used to study stem cell biology, develop new therapies, and gain insights into various medical conditions, [67].

6. Regenerative Medicine: Scientists are currently investigating the utilization of stem cells obtained from umbilical cord blood in the field of medicine with the objective of restoring or substituting damaged tissues and organs. Ongoing research indicates promising possibilities, for utilizing these cells in therapies, [68].

7. Limitations: Cord blood stem cells have some limitations. They may not be sufficient for larger individuals who require a high number of stem cells for transplantation. Additionally, their use is primarily limited to treating blood-related disorders and certain immune system disorders, [69].

To sum up stem cells found in cord blood hold value as they have the potential to be used in treating medical conditions, particularly those that are related to the blood and immune system, [70]. They are collected without harm to the baby or mother and can be stored for future use, making them a valuable option for families looking to secure potential medical treatments for their loved ones, [71].

AMNIOTIC FLUID STEM CELL

During pregnancy there is a kind of stem cell called fluid stem cells (AFSCs). These cells have attracted attention in the community because of their capacity to transform into types of cells, including those present, in the nervous system, muscles, bones and other bodily tissues, [73].

Here are some key points about amniotic fluid stem cells:

1. Source: AFSCs are usually obtained using a method known as amniocentesis. This procedure involves extracting a quantity of fluid, from the sac surrounding the growing fetus, [74].

2. Pluripotent Potential: These particular cells are often called "pluripotent" because they can developed into types of cells. However their versatility is not as wide ranging as that of stem cells, which have the potential to potentially change into any type of cell found in the body, [75].

3. Low Risk of Rejection: One benefit of utilizing AFSCs in applications is that they possess a reduced risk of rejection, by the immune system when transplanted into patients. This is due to their origin, from the individual (the fetus) in which they will be employed, [76].

4. Research and Clinical Applications: Scientists have extensively researched the applications of fluid stem cells, in fields, like medicine, tissue engineering and the treatment of different medical conditions. These conditions encompass disorders, diseases and congenital defects, [77].

5. Ethical Considerations: AFSCs don't pose the concerns, as embryonic stem cells, which involve destroying embryos. Nonetheless it's important to address regulatory considerations when utilizing AFSCs in research and clinical applications, [78].

It is worth noting that while there is promise, in using stem cells ongoing research is being conducted to better comprehend their capabilities and limitations. In applications different kinds of stem cells such, as induced pluripotent stem cells (iPSCs) or adult stem cells are often used, [79].

Properties and Potential of Stem Cells:

Stem cells have characteristics and abilities that have brought about advancements in the field of regenerative medicine. These traits encompass self-renewal enabling stem cells to multiply and generate stem cells along, with their capacity to specialize into various cell types.

Pluripotent Stem Cells; Pluripotent stem cells, which encompass both stem cells and induced pluripotent stem cells have brought about a transformation, in the realm of studying embryonic development, genome function and disease modeling (Mao et al., 2021). However the effective utilization of pluripotent stem cells, in these domains greatly depends on their capacity to transform into cell types (Morizane & Lam 2015).

Multipotent Stem Cells; Multipotent stem cells are a kind of stem cells that possess the capacity to transform into different types of cells within a specific lineage. Take stem cells for instance; they're classified as multipotent because they can specialize into cell types, like bone, cartilage, fat, muscle and connective tissue cells (Wu et al., 2014).

Unipotent Stem Cells; Unipotent stem cells possess a characteristic wherein they can only transform into a type of cell. This sets them apart, from pluripotent or multipotent cells, which have the capability to differentiate into cell types.

Self-Renewal and Proliferative Capacity: The idea of self-renewal involves stem cells replicating themselves to produce identical daughter stem cell. The ability of stem cells division and multiplication is known as their capacity. This process ensures a balance, between self-renewal and differentiation which's crucial for sustaining a pool of stem cells while also producing cells needed for tissue repair and regeneration.

Having an understanding of these characteristics of stem cells is vital in leveraging their potential across fields including medicine, disease modeling, drug discovery and therapeutic applications. Maintaining the equilibrium between self-renewal and differentiation plays a role in ensuring a constant supply of cells, for replenishing tissues. This knowledge contributes to the advancements in developing treatments for a range of conditions.

Stem Cell Niches and Microenvironment:

Stem cell environments play a role, in shaping how stem cells function affecting their longevity and abilities, rejuvenation, specialization and responsiveness, to signals. The niche represents an environment within a tissue that provides the cues and support for stem cells to function and maintain their unique characteristics. This environment comprises neighboring cells, extracellular matrix (ECM) signaling molecules and physical properties of the tissue. Gaining insights into the dynamics of stem cell niches and their interactions is essential, for advancing medicine and tissue engineering.

1. Components of the Stem Cell Niche:

a. neighboring cells:  Other types of cells, in the surrounding environment including fibroblasts, endothelial cells and various specialized cell types have an impact, on regulating the activities of stem cells.. These adjacent cells release chemical signals that offer assistance and impact the destiny and functioning of stem cells.

b. Extracellular Matrix (ECM): E.C.M network is made up of proteins and carbohydrates that has functions, in providing structural and biochemical support to cells. Stem cells engage with the ECM via receptors, on their cell surface. These interactions have the potential to impact their growth, specialization and movement.

Role of the Niche in Stem Cell Regulation:

a. Maintenance and Self-Renewal: The niche sends signals that help keep stem cells in a state where they don't specialize which supports their ability to renew themselves. This includes pathways such, as Wnt, Notch and BMP that prevent differentiation and sustain the stem cell properties..

b. Differentiation and Fate Specification: This process plays a role, in tissue healing and rejuvenation. The specialized area sends signals that stimulate stem cells to change into cell types based on the needs of the tissue, ediates stem cell responses to environmental cues, such as injury or inflammation, by modulating signaling pathways and instructing stem cells to contribute to tissue repair or regeneration.

2. Interactions with Surrounding Cells and ECM:

a. Direct Cell-Cell Interactions: Cells, in the niche communicate with cells by using receptors on their cell surface and signaling molecules, which affect how those neighboring cells behave and what ultimately happens to them.

b. Cell-ECM Interactions: Stem cells interact with components of the matrix (ECM), like collagen, fibronectin and laminin by utilizing receptors such as integrins. These interactions play a role, in shaping the behavior, movement and intercellular communication of stem cells.

c. Mechanical and Physical Cues:  The characteristics of the matrix (ECM) e.g, its stiffness and topography have an impact on how stem cells behave including their differentiation and migration. The physical surroundings influence the fate of stem cells through mechano-transduction pathways.

Ongoing research in this field continues to reveal insights, into how stem cells are regulated within their respective niches and how we can utilize this knowledge for therapeutic applications.

Stem Cells in Regenerative Medicine:

Stem cells have become an area of study, in medicine showing promise for addressing a range of diseases and injuries (K?l?ç et al. 2013). Scientists are exploring the characteristics of stem cells including their ability to develop into types of cells and their capacity for self-renewal. The aim is to transform how we treat conditions, like kidney and heart injuries as preserving fertility. Let’s take a look at how they're being used and some achievements, in clinical trials.

Applications in Tissue Engineering and Regeneration:

Tissue engineering and regeneration have become methods to tackle bone defects and advance medical treatments (Li et al., 2022). These methods involve utilizing techniques, like introducing seed cells, scaffolds and growth factors to rebuild and revive damaged or lost bone tissue. By combining these three elements tissue engineering aims to generate bone tissue. The field of tissue engineering and regeneration shows potential in meeting the demand, for innovative approaches to restore bones. It involves the replication and differentiation of cells to form tissue that replaces the damaged or lost tissue.

Here are some key aspects of tissue regeneration:

1. Cell Proliferation and Migration:  Cells, within the region undergo a process of multiplication and movement, towards the injured site triggering the initiation of regeneration. It's worth noting that different cell types possess levels of potential.

2. Stem Cells and Progenitor Cells: In this process of tissue regeneration occur. Their ability to transform into cell types is fundamental, for creating tissues.

3. Extracellular Matrix (ECM): E.C.M is responsible, for providing support and a structure that allows cells to stick together move around and specialize during the process of tissue regeneration. It plays a role, in directing cell activities and organizing tissues.

4. Signaling Pathways and Growth Factors: Numerous molecules and growth factors are important, in controlling the process of regeneration. These molecules facilitate communication, between cells. Synchronize activities, including cell growth, specialization and tissue arrangement.

5. Inflammation and Immune Response:  Inflammation occurs naturally as a response, to injury serving a purpose, in the process of tissue regeneration. It assists in clearing damaged tissue and initiates the recruitment of cells that contribute to the repair and renewal of the area.

6. Differentiation and Maturation: Cells at the injury site differentiate into specialized cell types to replace the damaged tissue. These cells then mature and organize to form functional tissue similar to the original tissue.

7. Factors Affecting Regeneration: Several factors can influence the regenerative capacity of tissues, including the type and extent of injury, the age and health of the individual, underlying medical conditions, and the presence of scar tissue.

8. Regenerative Medicine: Regenerative medicine is a field that focuses on harnessing the body's natural regenerative processes or using external interventions Promoting the healing and regrowth of tissues is achieved through methods, such, as utilizing stem cells, growth factors, gene therapy, tissue engineering techniques and biomaterials.

The promise of tissue regeneration, in treating diseases, injuries and conditions like cord injuries, heart disease, diabetes and degenerative disorders is incredibly encouraging.. Scientists are currently conducting research to gain an understanding of how tissue regeneration works and to create treatments that can improve and speed up the healing process.

Organ Transplantation: Organ transplantation is a procedure that saves lives and brings hope to patients suffering from end stage organ failure. The successful outcome of organ transplantation greatly depends on the availability of donor organs. These "bioengineered" organs have the potential to reduce transplant waiting times and address the scarcity of organ donors. The field of organ transplantation utilizing stem cells is rapidly. Holds promise for treating various medical conditions. Stem cells, a resource, in the fields of medicine and transplantation possess the remarkable capability to transform into various types of cells, there are types of stem cells, such, as induced pluripotent stem cells (iPSCs) and adult or somatic stem cells. Each type has its characteristics and potential applications, in transplantation.

Embryonic Stem Cell Transplantation: Transplanting stem cells is an area of regenerative medicine that offers significant potential, for treating a range of genetic and degenerative conditions (Fraidenraich & Benezra 2006). The utilization of stem cells, in transplantation has displayed encouraging outcomes in addressing degenerative diseases, for regenerating and replacing damaged tissues and organs. However it is important to address concerns and challenges related to tissue rejection, in this field.

Induced Pluripotent Stem Cell (iPSC) Transplantation: Transplanting induced pluripotent stem cells (iPSCs) is a groundbreaking technique, in medicine. It involves using reprogrammed adult cells to create stem cells that're tailor made for each patient. This remarkable ability allows these cells to potentially develop into types of cells making them a promising solution, for transplantation. By utilizing iPSCs we can effectively tackle concerns related to ethics and immune compatibility.

Adult or Somatic Stem Cell Transplantation:  Stem cells present, in the tissues and organs of our body have the ability to develop into cell types based on their origin. These extraordinary cells hold the potential to repair or regenerate damaged tissues when transplanted. The process involves isolating and cultivating the desired type of stem cells in a controlled laboratory environment guiding them to transform into the required cell types like those found in the heart or liver and ultimately implanting them into patients. However there are difficulties that emerge with the rejection of treatments and the potential, for the development of tumors. It is crucial to maintain control over the differentiation process to achieve the desired cell types. Ongoing research and clinical trials focus on optimizing stem cell based therapies improving transplant outcomes and addressing safety concerns associated with this field. It is advisable to seek advice from healthcare professionals and stay informed, about advancements as this field continues to evolve.

Wound Healing: Stem cells have proven to be beneficial, in expediting the healing of wounds those that're slow to heal. Therapies that involve stem cells can boost tissue repair and facilitate regeneration in areas that have been damaged. Stem cell utilization, in the field of wound healing is an area of investigation. It holds potential for enhancing the recovery process across kinds of wounds be it acute or chronic. Stem cells possess the ability to transform into types of cells playing a crucial role, in the regeneration and repair of tissues. There are techniques that can utilize these cells to facilitate the healing process of wounds.

Cell-based Therapies: Cell based treatments have potential in the field. They provide an avenue, for addressing diseases and injuries by utilizing the regenerative properties of stem cells. Through the manipulation and modification of these cells scientists have made strides in developing regenerative therapies.

Induced Pluripotent Stem Cells (iPSCs): iPSCs possess the ability to be reprogrammed enabling them to possess pluripotent qualities and giving them the capacity to develop into types of cells. This versatility makes them particularly valuable, in producing cells required for wound healing.

Direct Application of Stem Cells: MSCs have potential to be applied directly to wounds in order to speed up the process of healing. They promote tissue regeneration, reduce inflammation, and enhance blood vessel formation, ultimately aiding in wound closure.

Exosome and Paracrine Signaling: Stem cells have the ability to release substances, including growth factors, cytokines and exosomes. These substances play a role, in creating an environment, for wound healing by stimulating cell growth facilitating cell movement and promoting tissue restoration.

Tissue Engineering: Stem cells possess the characteristic to be mixed with biomaterials forming tissue engineered structures that imitate tissue. These structures can be utilized on wounds to assist in the process of healing and regrowth of tissues.

Gene Therapy with Stem Cells: Stem cells can be genetically structured to enhance their therapeutic properties, such as overexpression of specific growth factors or anti-inflammatory molecules. This approach can optimize their healing potential when applied to wounds.

Inflammation Modulation: Stem cells can modulate the immune response, which is critical during wound healing. They can help regulate inflammation and promote a balanced healing process.

Combination Therapies: Researchers are exploring combined approaches involving stem cells, growth factors, scaffolds, and other therapeutic modalities to optimize wound healing outcomes.

While stem cell-based approaches show promise in wound healing, further research, including clinical trials, is necessary to fully understand their potential, safety, and effectiveness in various wound types and patient populations. Furthermore it is crucial to give attention to concerns and regulatory protocols when developing and implementing wound healing therapies based on stem cells.

Dental Tissue Engineering: Stem cells are used to regenerate dental tissues like dentin, pulp, and even entire teeth. This offers promising solutions for dental tissue repair and restoration.

Musculoskeletal Regeneration: Stem cells possess the strength to be guided towards transforming into bone and cartilage cells, which offers possibilities, for addressing ailments such, as osteoarthritis and bone defects.

Clinical Trials and Success Stories:

Stem Cell Therapy for Spinal Cord Injury:  Researchers are presently conducting investigations to examine the use of stem cell therapy, in the treatment of cord injuries. Certain trials have displayed encouraging outcomes demonstrating enhancements, in patient’s motor abilities and overall quality of life.

Stem Cell-Based Cardiac Regeneration: Several clinical trials focus on using stem cells to regenerate heart tissue after myocardial infarction (heart attack). These trials aim to improve cardiac function and prevent heart failure.

Stem Cell Transplants for Blood Disorders: Stem cell transplants have shown effectiveness, in treating blood disorders like leukemia, lymphoma and sickle cell anemia. These transplants can restore the production of blood cells effectively.

Corneal Regeneration with Stem Cells: Stem cell-based treatments have been successful in regenerating corneal tissues and restoring vision in patients with corneal damage or disease.

Skin Regeneration: Stem cells are used in treating burns and chronic non-healing wounds by generating new skin cells, improving wound healing, and reducing scarring.

Ongoing research and clinical trials are constantly pushing the boundaries of our knowledge regarding stem cell therapies. These efforts aim to improve protocols. Ultimately make stem cell treatments a practice, in regenerative medicine. It is essential to recognize that with the progress made, Making sure that these treatments are safe and effective, in the field of medicine necessitates research and rigorous clinical trials before they can be widely accepted.

Stem Cells in Disease Modeling:

Stem cells play important role in disease modeling, offering a powerful tool to study both genetic and acquired diseases. These models can provide insights into disease mechanisms, drug screening, and potential therapeutic interventions. Disease specific stem cell models have proven to be highly valuable, in the study of diseases. Let me provide you with an overview of these models and their applications.

Disease-Specific Stem Cell Models:

Patient-Specific Induced Pluripotent Stem Cells (iPSCs): Induced pluripotent stem cells (iPSCs) that are tailored to each patient have revolutionized medicine. These iPSCs are created by reprogramming the patient’s cells resulting in genetically identical cells that minimize the chances of immune rejection and enhance the effectiveness of cell replacement therapy (Vieira et al., 2021).

Embryonic Stem Cells (ESCs): Embryonic stem cells are a kind of pluripotent stem cells that possess the capability to transform into any type of cell found in the human body. This extraordinary characteristic makes them extremely valuable, in the field of medicine as they hold the potential to mend injured tissues and organs (Shimizu et al., 2022). The immense promise presented by these cells has ignited a wave of enthusiasm and intensive investigation, among scientists as medical professionals delve into exploring how embryonic stem cells can be harnessed for treating an array of diseases and ailments.

Studying Genetic Diseases:

Monogenic Diseases: iPSCs obtained from individuals, with disorders (resulting from mutations in a gene) can undergo differentiation into cell types that are relevant, to the specific disease providing a means to investigate the underlying mechanisms of the disease.. Researchers can analyze disease-associated phenotypes and screen potential drug candidates for therapeutic development.

Polygenic Diseases: Polygenic disorders, which can be influenced by factors can also be replicated using induced pluripotent stem cells (iPSCs).Through the application of gene editing methods mutations that're relevant, to the disease can be introduced or rectified in iPSCs. This enables researchers to investigate the advancement of diseases and explore treatments..

Studying Acquired Diseases: Neurodegenerative Diseases: iPSCs can be differentiated into neurons, enabling the study of diseases like Alzheimer's, Parkinson's, and ALS. Researchers can investigate disease mechanisms, and neuronal function, and test potential drug candidates to slow or halt disease progression.

Cardiovascular Diseases: iPSCs can be differentiated into cardiac cells, providing a model for heart diseases like arrhythmias, cardiomyopathies, and congenital heart diseases. These models help in understanding disease mechanisms, drug screening, and the development of personalized treatments.

Cancer: iPSCs can be utilized to model cancer progression, enabling the study of tumor initiation, progression, and response to treatments. Using induced pluripotent stem cells (iPSCs) derived from patients the testing of cancer treatments has the potential to significantly improve their effectiveness.

Advantages of Disease-Specific Stem Cell Models:

Personalized Medicine: Disease models derived from patient-specific iPSCs enable personalized drug screening and treatment strategies.

Disease Mechanism Understanding: Studying stem cell models is valuable, in understanding how diseases work at the molecular levels. This knowledge is crucial, for developing treatments that target disease mechanisms.

Drug Discovery and Screening: These models help in the process of finding drugs by creating a platform where drug screening and toxicity testing can be done efficiently and safely within a controlled setting.

In summary, stem cell-based disease modeling provides a valuable approach to studying genetic and acquired diseases, advancing our understanding of pathophysiology and accelerating the development of targeted therapies for various conditions.

Stem Cell Transplantation:

Using induced pluripotent stem cells (iPSCs) derived from patients the testing of cancer treatments has the potential to significantly improve their effectiveness. In this essay we will delve into the intricacies of HSCT, its applications the hurdles it presents and how we manage the dreaded complication called graft, versus host disease (GVHD). Stem cell transplantation is a procedure where healthy stem cells are transferred to replace diseased cells in the body. It has proven to be a treatment, for diseases, including specific forms of cancer, genetic disorders and autoimmune conditions. A particular type of transplantation, known as hematopoietic stem cell transplantation (HSCT) concentrates on transplanting stem cells that're responsible, for producing types of blood cells. HSCT has become a treatment option for both non-cancerous conditions offering the potential, for potential cures or significant disease management.

A. Hematopoietic Stem Cell  Transplantation (HSCT)

There are two types of hematopoietic stem cell transplantation (HSCT); Hematopoietic stem cell transplantation is a procedure where doctors transplant stem cells to help patients regenerate their immune systems (Chen et al., 2023).

a. Autologous HSCT: In this method doctors. Store a patients stem cells, which are then reintroduced into the body after undergoing chemotherapy or radiation treatment. This approach is frequently employed to treat lymphomas, multiple myeloma and specific types of tumors.

b. Allogeneic HSCT:  Allogeneic hematopoietic stem cell transplantation (HSCT) can be performed by obtaining stem cells from either a brother or sister or, from someone who's not genetically related. These collected cells are then introduced into the patient after they have undergone conditioning treatments. This specific type of transplantation is often utilized to address conditions such, as leukemia, lymphoma and aplastic anemia.

B. Pre-transplant Preparations: Prior, to undergoing HSCT (Hematopoietic Stem Cell Transplantation) a comprehensive evaluation of the patients health is performed. This includes assessing the disease status evaluating organ function and screening for any existing infections. To prepare the patient for the transplant conditioning regimens are implemented. These regimens typically involve chemotherapy and/or radiation treatments, with the goal of suppressing the system and eliminating any remaining disease before transplantation takes place.

C. Transplant Procedure: After the conditioning phase the stem cell infusion takes place. These infused stem cells travel to the bone marrow, where they go through differentiation and repopulate the lineages of blood cells. It's essential to monitor and provide care during the recovery period.

D. Post-transplant Follow-up: After the transplant it is crucial to monitor the patient to promptly identify and address any complications. This involves keeping an eye on factors such, as engraftment, the rejection of grafts.

Clinical Applications of HSCT

HSCT has diverse clinical applications, including but not limited to:

1. Hematological Malignancies: Treatment of leukemias, lymphomas, multiple myeloma, myelodysplastic syndromes, and other blood-related cancers.

2. Bone Marrow Failure Syndromes: Bone marrow failure is a condition that includes anemia pure red cell aplasia and other disorders..

3. Immune Disorders: Severe combined immunodeficiency (SCID) is a condition that impacts the system. It is often associated with immune deficiencies, such, as Wiskott Aldrich syndrome.

4. Metabolic Disorders: Hurler syndrome, adrenoleukodystrophy, and certain lysosomal storage disorders.

5. Autoimmune Diseases: Experimental treatments for severe autoimmune diseases like systemic sclerosis and multiple sclerosis.

6. Solid Organ Transplant Tolerance Induction: Exploratory research endeavors, with the goal of promoting acceptance of organ transplants.

Challenges in HSCT

A. Graft Rejection

Graft rejection happens when the recipient’s immune system identifies the cells as foreign and launches an attack, against them. To reduce this risk different approaches are used, such as selecting donors and implementing conditioning regimens.

B. Graft Failure

Graft failure involves the inability of infused stem cells to engraft and produce the desired effect. Optimized pre-transplant patient assessment and conditioning regimens are vital to prevent graft failure.

C. Infection

The post-transplant period is associated with a heightened risk of infections due to compromised immune function. Prophylactic measures and vigilant monitoring are crucial to prevent and manage infections effectively.

Graft-versus-Host Disease (GVHD)

A. Definition & Pathophysiology

After undergoing a stem cell transplant (HSCT) there is a possibility of developing graft, versus host disease (GVHD) which's a potential complication. In this condition the immune cells from the donor mistakenly identify the recipient’s tissues as foreign. Launch an attack, against them. Acute and chronic GVHD have characteristics and develop over distinct periods of time.

B. Clinical Manifestations

After undergoing a stem cell transplant (HSCT) there is a possibility of developing graft, versus host disease (GVHD) which's a potential complication. In this condition the immune cells from the donor mistakenly recognize the recipient’s tissues as foreign. Mount an attack, against them. Acute and chronic GVHD exhibit characteristics. Develop over different time periods.

C. GVHD Management

GVHD management involves a multi-faceted approach, including:

a. Immunosuppressive Therapy: The primary treatment, for GVHD involves the use of corticosteroids and other medications that suppress the system to control responses..

b. Supportive Care: Symptomatic management to address specific organ involvement and complications.

c. Experimental Therapies: Investigational approaches, such as photopheresis and biological agents, are being explored to improve GVHD outcomes.

Hematopoietic stem cell transplantation is a complex and evolving field with extensive clinical applications. However there are difficulties to consider such, as the risk of the body rejecting the graft, It is essential to have an understanding of the complications associated with graft failure versus host disease in order to enhance the overall success and safety of stem cell transplantation thereby improving patient outcomes. Ongoing research and advancements in the field aim to further refine transplantation techniques and GVHD management, ultimately benefiting a broader spectrum of patients in need.

Bioengineering and Stem Cells:

Bioengineering and stem cell research hold promise, for making advancements in medicine, disease modeling, drug discovery and tissue engineering. Allow me to give you an overview of these subjects.:

a. Biomaterials for Stem Cell Growth and Differentiation:

Biomaterials have a role, in the fields of stem cell research and tissue engineering. They create an environment that supports the growth, differentiation and maturation of stem cells into types of cells. In this pursuit scientists employ a range of biomaterials, like hydrogels, scaffolds and nanoparticles to imitate the matrix (ECM) and steer the behavior of stem cells.

1. Hydrogels: Hydrogels are water-swollen networks of polymer chains that resemble the ECM's physical properties. They can encapsulate stem cells and deliver bioactive molecules to promote specific differentiation pathways.

2. Scaffolds: Scaffolds crafted from materials that're compatible, with the human body serve as a framework, for stem cells. They help these cells to attach, multiply and develop into types of cells. These scaffolds can be designed to replicate the structure of our body tissues.

3. Nanoparticles: Nanoparticles have the potential to be utilized in applications such, as administration of medications manipulation of genes and observation of stem cell activities. They can effectively transport growth factors.

b. 3D Printing and Bioprinting in Stem Cell Research:

Recent developments, in printing and bioprinting have made contributions to the advancements, in tissue engineering and regenerative medicine. These innovations allow for the fabrication of three structures, such, as scaffolds and tissue constructs by depositing biomaterials and cells layer by layer.

1. Scaffold Fabrication: The utilization of 3D printing allows for the production of tailor made scaffolds, which have designs that aid, in the insertion of stem cells and direct their development into cell types.

2. Bioprinting of Tissues and Organs: 3D printing enables the creation of customized scaffolds, with structures facilitating the implantation of stem cells and guiding their differentiation into cell types.

c. Microfluidics and Stem Cell Research:

Microfluidics involves manipulating small amounts of fluids and cells within microscale channels or devices. In stem cell research, microfluidic systems offer precise control over the cellular microenvironment and can replicate in vivo conditions.

1. Cell Culture and Analysis: Microfluidic devices enable precise control over culture conditions, including nutrient supply, oxygen levels, and waste removal. They facilitate real-time monitoring and analysis of stem cell behavior and responses.

2. High-Throughput Screening: Microfluidic systems offer a tool, for conducting drug screening and toxicity assessments on stem cells. This enables researchers to efficiently assess the impact of substances on aspects such, as cell viability, proliferation and differentiation.

Biomaterials, 3D printing, bioprinting and microfluidics play roles in the realm of stem cell research and bioengineering. These technologies offer approaches, to investigating stem cells creating tissue engineered structures and pushing forward the progress of treatments.

Ethical and Legal Considerations:

Research involving stem cells shows promise. Holds the potential to bring about significant advancements in medical treatments while also deepening our knowledge of different diseases. However, it also raises significant ethical and legal considerations. Let's delve into each aspect:

Ethical Implications of Stem Cell Research:

1. Source of Stem Cells:

• Embryonic stem cells (ESCs) are obtained from embryos, which raises concerns regarding the termination of life.
• Induced pluripotent stem cells (iPSCs) and adult stem cells offer potential. There are still concerns surrounding their use and management.

2. Informed Consent: Obtaining the consent of donors and patients is of importance when it comes to utilizing stem cells particularly in cases involving delicate substances such, as embryos or fetal tissue.

3. Equitable Access: Ethical considerations center, around the importance of making sure that the advantages of stem cell research are within reach and affordable for everyone regardless of their socio status, than being limited to only those who are privileged.

4. Human Cloning: The potential for human cloning using stem cells raises significant ethical concerns related to identity, autonomy, and the creation of life for research or therapeutic purposes.

5. Genetic Modification: Genetic editing technologies like CRISPR-Cas9 raise ethical dilemmas regarding modifying the human germline and the potential for creating "designer babies."

6.  Medical Tourism: Stem cell treatments offered in countries with lax regulations may lack proper oversight and pose risks to patients, raising ethical concerns about exploitation and patient safety.

7. Transparency and Accountability: Maintaining transparency in research, data sharing, and accurate representation of results is crucial to upholding the integrity of stem cell research and maintaining public trust.

Regulations and Guidelines Governing Stem Cell Research:

1. National Regulations: Different countries have varying laws and regulations regarding stem cell research, often addressing issues such as source types, permissible research, and funding.
2. International Guidelines: Organizations, like the International Society, for Stem Cell Research (ISSCR) provide guidance regarding the protocols to be followed when conducting research that involves stem cells.
3. Ethics Committees and Review Boards: Usually institutions have ethics committees or review boards known as review boards (IRBs). Their main role is to assess and give approval to research proposals involving stem cells making sure they adhere to guidelines and legal requirements.
4. Funding Regulations: Public and private funding institutions frequently establish guidelines regarding the allocation of funds, for stem cell research aiming to ensure adherence, to legal norms.

Public Perception and Controversies in Stem Cell Research:

1. Religious and Cultural Perspectives: Different religious and cultural beliefs influence public perception, with some opposing specific aspects of stem cell research based on their moral or religious doctrines.
2. Media Influence: The media's portrayal of stem cell research can shape public opinion and influence policy decisions, either promoting its potential benefits or raising ethical concerns.
3. Patient Advocacy and Interest Groups: Groups can advocate for or against specific stem cell research practices based on their beliefs about potential benefits, ethical considerations, and patient rights.
4. Controversies in Research Findings: Public perception can be affected by controversies surrounding research findings, scientific misconduct, or misuse of stem cell technologies, impacting trust in the field.
5. Public Education and Awareness: Adequate public education and awareness campaigns are vital to address misconceptions, clarify ethical boundaries, and foster an informed understanding of stem cell research.

Finding a ground that takes into account the advantages of stem cell research well as the ethical and legal concerns it raises is of utmost importance. This balance ensures advancement in this area while also maintaining trust and confidence. To navigate these considerations it is essential to engage in discussions involve all relevant parties and adhere to established guidelines.

Emerging Technologies and Future Directions:

Cutting edge technologies, such, as CRISPR Cas9 are playing a role, Single cell technologies, along with the integration of intelligence (AI) and machine learning are crucial, in shaping the future of stem cell research and gene editing.

a. CRISPR-Cas9 and Gene Editing in Stem Cells:

CRISPR Cas9 is a breakthrough, in the field of gene editing enabling accurate and targeted modifications of the genetic material within cells. In the context of stem cells, CRISPR-Cas9 has immense potential to advance research and therapies. Here's how:

1. Gene Editing for Disease Modeling: Scientists are able to create models of diseases using stem cells thanks, to the advancements, in CRISPR Cas9 technology, which allows them to introduce mutations that are associated with diseases. This creates a platform, for studying the mechanisms underlying these diseases and, for screening therapeutic compounds.
2. Correcting Genetic Defects in Stem Cells: CRISPR-Cas9 can be used to correct genetic mutations in stem cells, offering potential therapeutic strategies for genetic disorders. Stem cells edited using CRISPR-Cas9 could potentially be used for regenerative medicine.
3. Enhancing Desired Traits: CRISPR-Cas9 can be employed to enhance specific traits in stem cells, such as their differentiation potential or resistance to certain diseases, ultimately improving their therapeutic efficacy.
4. Drug Discovery and Screening: Using gene edited stem cells is an approach, for drug discovery and assessing toxicity. It allows for a understanding of human biology and how our bodies respond to different medications.

b. Single-Cell Technologies in Stem Cell Research:

Single-cell technologies are a group of cutting-edge tools that allow the analysis and manipulation of individual cells, providing insights into cellular heterogeneity and function. In stem cell research, these technologies are invaluable:

1. Single-Cell RNA Sequencing (scRNA-seq): Researchers are able to analyze the patterns of gene expression, in stem cells, which provides them with insights, into the various cell types stages of development and how cells behave over time..
2. Single-Cell Epigenomics: These techniques help in understanding the epigenetic modifications in individual stem cells, shedding light on gene regulation and cell fate decisions.
3. Single-Cell Proteomics: Analyzing proteins at the single-cell level helps in understanding protein expression variations and post-translational modifications critical for stem cell function and differentiation.

Artificial Intelligence and Machine Learning Applications in Stem Cell Research:

AI and machine learning are transforming the field of stem cell research by enhancing data analysis enabling modeling and facilitating decision making. Let’s delve into how AI's making an impact, in this particular domain;

1. Data Analysis and Integration: AI algorithms have the capability to analyze quantities of data related to stem cells, including genomics, proteomics, and imaging data, to extract patterns and correlations that may not be apparent to human analysts.
2. Predicting Cellular Behavior: AI models can predict stem cell behavior, differentiation trajectories, and response to stimuli, aiding in the optimization of culture conditions and differentiation protocols.
3. Drug Discovery and Repurposing: AI can accelerate the drug discovery process by predicting the efficacy and safety of potential drugs for specific diseases, including those related to stem cell therapies.
4. Personalized Medicine: AI can help personalize stem cell-based therapies by analyzing patient data and predicting the most effective treatments based on individual characteristics.

In short the areas of stem cell research and regenerative medicine are currently making progress thanks, to the combination of CRISPR Cas9 single cell technologies and AI applications. These advancements have the potential to revolutionize disease modeling and drug discovery. Personalized therapies and advancements, in stem cell research have led to improvements. By integrating these cutting edge technologies we can expect the development of methods, for studying stem cells and exploring their wide range of applications.

Clinical Trials and Translational Research:

Overview of Ongoing Stem Cell Clinical Trials:

Clinical trials play a role, in evaluating the safety and efficacy of stem cell treatments, for medical conditions. As of September 2021 there are trials focused on investigating the potential of stem cells in treating a range of health problems. Here's a brief summary;

1. Neurological Disorders: Scientists are currently carrying out experiments to investigate the possibilities of using stem cells for treating conditions, like Parkinsons disease, Alzheimers disease, spinal cord injuries and multiple sclerosis. The main objective of these trials is to evaluate whether stem cells can effectively replace damaged neurons and aid in the process of recovery.
2. Cardiovascular Disorders: Ongoing trials are exploring stem cell therapies for heart failure, myocardial infarction, and other cardiac conditions. Stem cells may help regenerate cardiac tissue and improve heart function.
3. Orthopedic Conditions:  Scientists are currently studying the uses of stem cells in treatments related to bones and cartilage regeneration in conditions such as osteoarthritis, joint injuries, and fractures.
4. Diabetes and Metabolic Disorders: Stem cell studies are currently evaluating their ability to produce cells that can generate insulin with the aim of using them in the treatment of diabetes. Moreover scientists are presently exploring the impact of stem cells, on the treatment and control of metabolic disorders.
5. Cancer Treatment:  Scientists are currently conducting studies to explore the potential of utilizing stem cells, for cancer treatment. This includes exploring methods such, as delivering agents to affected areas and boosting the bodys immune response, to combat cancer.
6. Ophthalmic Conditions:  Current research studies are currently dedicated to the progress of stem cell treatments, for the management of age related macular degeneration and disorders pertaining to the cornea, the objective is to restore vision, in individuals affected by these conditions.
7. Gastrointestinal Disorders: Scientists are currently conducting research to investigate the use of stem cells, in treating medical conditions, like Crohns disease, colitis and liver diseases.

The primary objective of these trials is to evaluate the safety, dosage, methods of administration and efficacy of therapies based on stem cells, for medical conditions. The findings from these trials will serve as a groundwork, for treatments.

Challenges and Advancements in Stem Cell-Based Therapies:

Challenges:

1. Safety Concerns:  The main goal of these trials is to assess the safety, dosage, methods of administration and efficacy of treatments involving stem cells. This research seeks to lay the foundation, for treatments.
2. Standardization and Regulation: It is essential to have procedures in place, for isolating expanding and administering stem cells. Regulatory frameworks should continuously adapt to advancements in order to maintain safety and effectiveness.
3. Ethical Considerations: The ethical aspects surrounding the origin of stem cells, such, as those derived from adults, induced pluripotent stem cells for their application, in research and medical treatment remain a subject of ongoing deliberation.
4. Long-Term Efficacy and Monitoring: In order to fully understand the potential and drawbacks of stem cell treatments it is crucial to evaluate their effectiveness over a period of time. Closely monitor outcomes, over extended periods of time.

Advancements:

1. Induced Pluripotent Stem Cells (iPSCs): iPSC technology allows adult cells to be converted into a state that addresses concerns associated with stem cells. This process provides a customized cell source that caters, to the needs of each patient.
2. CRISPR-Cas9 Gene Editing: CRISPR technology allows for accurate gene editing in stem cells, which's essential, for correcting abnormalities and enhancing the safety and effectiveness of stem cell treatments.
3. Exosome Research: Exosomes, small vesicles released by stem cells, have shown therapeutic potential in modulating inflammation, enhancing the healing process of tissues. Augmenting the benefits of treatments utilizing stem cells.
4. Biomaterials and Scaffolds: Advancements in biomaterials and scaffold technologies enhance the delivery and integration of stem cells into target tissues, optimizing their therapeutic effects.
5. Combination Therapies: Ongoing studies, on the biology and behavior of stem cells play a role, in discovering their capabilities and obstacles ultimately aiding in the advancement of treatments.

Stem Cells and Aging:

Research indicates that stem cells play a role, in the aging process and have garnered interest due to their potential, in strategies aimed at regeneration and rejuvenation. Let's delve into the details of their role in aging and how they can be utilized for rejuvenation.

a. Role of Stem Cells in the Aging Process:

1. Decline in Stem Cell Function: As people get older the effectiveness and ability of stem cells to regenerate decline. This decrease is noticeable, in both the quantity of stem cells and their capability to transform into cells depends on various factors, such as telomeres, DNA damage, oxidative stress and changes, in signaling pathways play a role in this decline.
2. Accumulation of Damaged Cells: As we get older our bodies accumulate senescent cells, which're cells that can no longer divide and reproduce. These senescent cells can secrete inflammatory molecules and harmful substances, contributing to tissue dysfunction and age-related diseases.
3. Impaired Tissue Repair: The diminished capacity of stem cells to regenerate greatly impacts the bodys capability to effectively heal and restore damaged tissues and organs.. This leads to a decline in organ function, which is a hallmark of aging.
4. Microenvironment Changes: The stem cell microenvironment, or niche, undergoes alterations during aging. The therapies utilize the abilities of stem cells to regenerate and revitalize cells and tissues that have experienced the effects of aging or deterioration. This can be accomplished by introducing either stem cells themselves or their specialized counterparts, into the body with the goal of restoring functionality and promoting healing in injured organs.

Regenerative Potential and Rejuvenation Strategies using Stem Cells:

1. Stem Cell-based Therapies: utilize the power of stem cells to replenish and renew cells and tissues that have been affected by damage or aging. This can be achieved by introducing stem cells or their specialized counterparts, into the body aiming to restore functionality and heal injured organs.
2. Induced Pluripotent Stem Cells (iPSCs): iPSCs, which have been modified to exhibit characteristics of stem cells possess the ability to transform into types of cells offering potential, in the field of regenerative medicine. These cells are valuable, in producing cell types that can replace damaged cells in aging individuals.
3. Stem Cell Activation and Mobilization: There are ways to stimulate the activation of stem cells that exist within the body. These methods focus on promoting the growth, development and movement of these cells towards areas that require repair or have experienced aging. This can be accomplished by using medications or substances that boost the activity of stem cells as, by utilizing growth factors.
4. CRISPR-Cas9 and Gene Editing: CRISPR Cas9, a tool, for editing genes has the ability to alter the composition of stem cells. By doing it can enhance their ability to regenerate and reverse age related alterations. This process may include fixing mutations or adjusting signaling pathways to restore function in stem cells.
5. Exosome Therapy: Stem cell-derived exosomes, which contain bioactive molecules, can be isolated and used to modulate cellular signaling and tissue regeneration. Exosome therapy has shown promise in promoting tissue repair and reducing inflammation associated with aging.
6. CombinationTherapies: Combining stem cell-based approaches with other interventions, such as lifestyle modifications (e.g., diet, exercise), could maximize the regenerative potential and overall effectiveness of rejuvenation strategies. Ongoing studies are being conducted exploring the stem cells. Aging with the goal of enhancing our understanding of the processes involved and creating beneficial treatments to address age related deterioration. The ultimate aim is to enhance the wellbeing of individuals and improve their quality of life.

ACKNOWLEDGEMENT:

The authors extend their sincere appreciation to the co-authors and staff of the Department of Biochemistry, Chemistry and Industrial Chemistry, Kwara State University (KWASU), Malete, Kwara State, for their generous support throughout.

REFERENCES

1. Zakrzewski W, Dobrzy?ski M, Szymonowicz M, et al. Stem cells: past, present, and future. Stem Cell Res Ther. 2019;10:68.
2. Poliwoda S, Noor N, Downs E, Schaaf A, Cantwell A, Ganti L, et al. Stem cells: a comprehensive review of origins and emerging clinical roles in medical practice. Orthop Rev (Pavia). 2022 Aug 25;14(3):37498.
3. Kim KH, Jeon TJ, So YI, Shin YK, Lee HJ. Stem cell therapy in liver disease. Int J Stem Cells. 2023;16:251–9.
4. Bacman S, Williams S, Pinto M, et al. Specific elimination of mutant mitochondrial genomes in patient-derived cells by mito TALENs. Nat Med. 2013;19:1111–3.
5. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282(5391):1145–7.
6. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663–76.
7. Daley GQ, Scadden DT. Prospects for stem cell-based therapy. Cell. 2008;132(4):544–8.
8. Wu SM, Hochedlinger K. Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Nat Cell Biol. 2011;13(5):497–505.
9. Trounson A, McDonald C. Stem cell therapies in clinical trials: progress and challenges. Cell Stem Cell. 2015;17(1):11–22.
10. Weissman IL. Stem cells: units of development, units of regeneration, and units in evolution. Cell. 2000;100(1):157–68.
11. Liao J, Cui C, Chen S, et al. Generation of induced pluripotent stem cells from human hair follicles. Nature. 2009;461(7264):367–72.
12. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861–72.
13. Belmonte JC, Ellis J, Hochedlinger K. Induced pluripotent stem cells and reprogramming: seeing the science through the hype. Nat Rev Genet. 2009;10(12):878–83.
14. Trounson A, DeWitt ND. Pluripotent stem cells progressing to the clinic. Nat Rev Mol Cell Biol. 2016;17(3):194–200.
15. Soria-Valles C, López-Otín C. iPSC technology as a platform for disease modeling and drug screening. Methods Enzymol. 2016;476:35–43.
16. Sánchez L, Gutierrez-Aranda I, Ligero G, et al. Enrichment of human ESC-derived multipotent mesenchymal stem cells with immunosuppressive and anti-inflammatory properties capable of protecting against experimental inflammatory bowel disease. Stem Cells. 2012;30(12):2611–24.
17. Soria-Valles C, López-Otín C. iPSC technology as a platform for disease modeling and drug screening. Methods Enzymol. 2016;476:35–43.
18. Ellerstrom C, Strehl R, Noaksson K, Hyllner J, Semb H. Facilitated expansion of human embryonic stem cells by single-cell enzymatic dissociation. Stem Cells. 2007;25:1690–6.
19. Kurosawa HY. Methods for inducing embryoid body formation: in vitro differentiation system of embryonic stem cells. J Biosci Bioeng. 2007;103:389–98.
20. Mohr JC, de Pablo JJ, Palecek SP. 3-D microwell culture of human embryonic stem cells. Biomaterials. 2006;27(36):6032–42.
21.  Solter D, Knowles BB. Immunosurgery of mouse blastocyst. Proc Natl Acad Sci U S A. 1975;72:5099–102.
22. Bloushtain-Qimron N. Epigenetic patterns of embryonic and adult stem cells. Cell Cycle. 2009;8:809–17.
23. Vaes B, Craeye D, Pinxteren J. Quality control during manufacture of a stem cell therapeutic. BioProcess Int. 2012;10:50–5.
24. Ludwig TE, Bergendahl V, Levenstein ME, et al. Feeder-independent culture of human embryonic stem cells. Nat Methods. 2006;3:637–46.
25. Turner N, Grose R. Fibroblast growth factor signaling: from development to cancer. Nat Rev Cancer. 2010;10:116–29.
26. Rao TP, Kuhl M. An updated overview on Wnt signaling pathways: a prelude for more. Circ Res. 2010;106:1798–806.
27. Moustakas A, Heldin CH. The regulation of TGFbeta signal transduction. Development. 2009;136:3699–714.
28. Cai J, Zhao Y, Liu Y, et al. Directed differentiation of human embryonic stem cells into functional hepatic cells. Hepatology. 2007;45:1229–39.
29. Burridge PW, Zambidis ET. Highly efficient directed differentiation of human induced pluripotent stem cells into cardiomyocytes. Methods Mol Biol. 2013;997:149–61.
30. Vallier L, Reynolds D, Pedersen RA. Nodal inhibits the differentiation of human embryonic stem cells along the neuroectodermal default pathway. Dev Biol. 2004;275:403–21.
31. Chen G, Gulbranson DR, Hou Z, et al. Chemically defined conditions for human iPSC derivation and culture. Nat Methods. 2011;8(5):424–9.
32. Wang L, Schulz TC, Sherrer ES, et al. Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling. Blood. 2007;110(12):4111–9.
33. Zhou W, Freed CR. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells. Stem Cells. 2009;27(11):2667–74.
34. Chen AE, Egli D, Niakan K, et al. Optimal timing of inner cell mass isolation increases the efficiency of human embryonic stem cell derivation. Stem Cells. 2009;27(12):2797–803.
35. Desbordes SC, Studer L. Adapting human pluripotent stem cells to high-throughput and high-content screening. Nat Protoc. 2013;8(6):111–30.
36. Itskovitz-Eldor J, Schuldiner M, Karsenti D, et al. Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol Med. 2000;6(2):88–95.
37. Baharvand H, Ashtiani SK, Valojerdi MR, et al. Establishment and in vitro differentiation of a new embryonic stem cell line from human blastocyst. Differentiation. 2004;72(5):224–9.
38. Dravid G, Ye Z, Hammond H, et al. Defining the role of Wnt/beta-catenin signaling in the survival, proliferation, and self-renewal of human embryonic stem cells. Stem Cells. 2005;23(10):1489–501.
39. Schuldiner M, Itskovitz-Eldor J, Benvenisty N. Selective ablation of human embryonic stem cells expressing a "suicide" gene. Stem Cells. 2003;21(3):257–65.
40. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature. 1981;292(5819):154–6.
41. Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A. 1981;78(12):7634–8.
42. Reubinoff BE, Pera MF, Fong CY, et al. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol. 2000;18(4):399–404.
43. Humphrey RK, Beattie GM, Lopez AD, et al. Maintenance of pluripotency in human embryonic stem cells is STAT3 independent. Stem Cells. 2004;22(4):522–30.
44. Amit M, Carpenter MK, Inokuma MS, et al. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol. 2000;227(2):271–8.
45. Xu C, Inokuma MS, Denham J, et al. Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol. 2001;19(10):971–4.
46. Li Y, Powell S, Brunette E, et al. Expansion of human pluripotent stem cells in defined xeno-free, feeder-free conditions. Nat Protoc. 2018;13(9):2103–20.
47. Amit M, Itskovitz-Eldor J. Derivation and spontaneous differentiation of human embryonic stem cells. J Anat. 2002;200(3):225–32.
48. Amit M, Margulets V, Segev H, et al. Human feeder layers for human embryonic stem cells. Biol Reprod. 2003;68(6):2150–6.
49. Wang L, Menendez P, Shojaei F, et al. Human embryonic stem cell-derived hematopoietic cells are capable of engrafting primary human recipients. Blood. 2005;106(5):1565–73.
50. Zhang SC, Wernig M, Duncan ID, et al. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol. 2001;19(12):1129–33.
51. McDonald J, Liu Y, Qu W, et al. Transplanted embryonic stem cells survive, differentiate, and promote recovery in injured rat spinal cord. Nat Neurosci. 1999;2(10):991–3.
52. Wichterle H, Lieberam I, Porter JA, Jessell TM. Directed differentiation of embryonic stem cells into motor neurons. Cell. 2002;110(3):385–97.
53. Kehat I, Kenyagin-Karsenti D, Snir M, et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest. 2001;108(3):407–14.
54. Osafune K, Caron L, Borowiak M, et al. Marked differences in differentiation propensity among human embryonic stem cell lines. Nat Biotechnol. 2008;26(3):313–5.
55. Murry CE, Keller G. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell. 2008;132(4):661–80.
56. Blum B, Benvenisty N. The tumorigenicity of human embryonic stem cells. Adv Cancer Res. 2008;100:133–58.
57. Ben-David U, Benvenisty N. The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat Rev Cancer. 2011;11(4):268–77.
58. Blum B, Bar-Nur O, Golan-Lev T, Benvenisty N. The anti-apoptotic gene survivin contributes to teratoma formation by human embryonic stem cells. Nat Biotechnol. 2009;27(3):281–7.
59. Amariglio N, Hirshberg A, Scheithauer BW, et al. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med. 2009;6(2):e1000029.
60. Chung Y, Klimanskaya I, Becker S, et al. Embryonic and extraembryonic stem cell lines derived from single mouse blastomeres. Nature. 2006;439(7073):216–9.
61. Klimanskaya I, Chung Y, Becker S, et al. Human embryonic stem cell lines derived from single blastomeres. Nature. 2006;444(7118):481–5.
62. Smetana K, Zák R. The nucleolus: an organelle formed by the act of building a ribosome. Nucleus. 2019;10(1):1–10.
63. International Stem Cell Initiative. Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol. 2011;29(12):1132–44.
64. Suemori H, Tada T, Torii R, et al. Establishment of embryonic stem cell lines from human blastocysts: timing of inner cell mass isolation and properties of derived lines. Dev Dyn. 2006;235(1):247–58.
65. Lu SJ, Li F, Yin H, et al. Generation of functional hemangioblasts from human embryonic stem cells. Nat Methods. 2007;4(6):501–9.
66. Barberi T, Klivenyi P, Calingasan NY, et al. Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice. Nat Biotechnol. 2003;21(10):1200–7.
67. Xu RH, Peck RM, Li DS, et al. Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat Methods. 2005;2(3):185–90.
68. Fong CY, Gauthaman K, Bongso A. Teratomas from pluripotent stem cells: a clinical hurdle. J Cell Biochem. 2010;111(4):769–81.
69. Knoblich JA. Mechanisms of asymmetric stem cell division. Cell. 2008;132(4):583–97.
70. Reubinoff BE, Pera MF, Vajta G, et al. Efficient derivation of human embryonic stem cell lines from cryopreserved blastocysts. Hum Reprod. 2001;16(4):707–14.
71. Cowan CA, Klimanskaya I, McMahon J, et al. Derivation of embryonic stem-cell lines from human blastocysts. N Engl J Med. 2004;350(13):1353–6.
72. Ludwig TE, Bergendahl V, Levenstein ME, et al. Feeder-independent culture of human embryonic stem cells. Nat Methods. 2006;3(8):637–46.
73. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature. 2007;448(7151):313–7.
74. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663–76.
75. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861–72.
76. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318(5858):1917–20.
77. Stadtfeld M, Nagaya M, Utikal J, et al. Induced pluripotent stem cells generated without viral integration. Science. 2008;322(5903):945–9.
78. Okita K, Nakagawa M, Hyenjong H, et al. Generation of mouse induced pluripotent stem cells without viral vectors. Science. 2008;322(5903):949–53.
79. Yu J, Hu K, Smuga-Otto K, et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science. 2009;324(5928):797–801.
80. Fink T, Lund P, Pilgaard L, et al. Instability of standard PCR reference genes in adipose-derived stem cells during propagation, differentiation, and hypoxic exposure. BMC Mol Biol. 2008;9(1):1–9.